查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1719119

抗菌藥物敏感性測試市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、技術、應用、最終用戶、地區和競爭細分，2020-2030 年）

Antimicrobial Susceptibility Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technique, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球抗菌藥物敏感性測試 (AST) 市場價值為 44.1 億美元，預計到 2030 年將達到 59.8 億美元，預測期內複合年成長率為 5.17%。隨著抗生素抗藥性成為全球緊迫的健康問題，市場正在大幅擴張，需要準確、及時的診斷工具。 AST 在指導臨床醫生選擇適當的抗生素治療、降低治療失敗率和遏制抗菌劑的濫用方面發揮關鍵作用。多重抗藥性感染的日益普及以及全球對抗菌素抗藥性 (AMR) 認知的提高，提升了對可靠 AST 解決方案的需求。快速自動化診斷系統的進步正在加速其應用，尤其是在醫院和診斷實驗室。此外，人工智慧和機器學習與 AST 平台的整合正在提高精確度和效率，使 AST 成為個人化和精準醫療的重要組成部分。

市場概覽
預測期 2026-2030
2024年市場規模 44.1億美元
2030年市場規模 59.8億美元
2025-2030 年複合年成長率 5.17%
成長最快的領域 藥物開發
最大的市場 北美洲

關鍵市場促進因素

傳染病發生率上升

主要市場挑戰

缺乏標準化和驗證

主要市場趨勢

向自動化和高通量系統轉變

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球抗菌藥物敏感性測試市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（手動測試{MIC 試紙、藥敏試驗盤、藥敏板}、自動化儀器、耗材及培養基）
    • 依技術（自動 AST、Etest 方法、稀釋、紙片擴散、其他）
    • 按應用（藥物開發、藥敏試驗、其他）
    • 按最終用戶（醫院、診斷實驗室、生物技術和製藥公司等）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美抗菌藥物敏感性測試市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲抗菌藥物敏感性測試市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區抗菌藥物敏感性測試市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美抗菌藥物敏感性測試市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲抗菌藥物敏感性測試市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Bio-Rad Laboratories Inc.
  • Merck & Co., Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • bioMerieux SA
  • Becton, Dickinson and Company
  • ELITech Group SAS
  • F. Hoffmann-La Roche Ltd.
  • Accelerate Diagnostics, Inc.
  • HiMedia Laboratories Private Limited

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 15570

The Global Antimicrobial Susceptibility Testing (AST) Market was valued at USD 4.41 billion in 2024 and is projected to reach USD 5.98 billion by 2030, growing at a CAGR of 5.17% during the forecast period. The market is expanding significantly as antibiotic resistance becomes a pressing global health concern, prompting the need for accurate, timely diagnostic tools. AST plays a pivotal role in guiding clinicians toward appropriate antibiotic treatments, reducing therapy failure rates and curbing the misuse of antimicrobial agents. The growing prevalence of multidrug-resistant infections and the increased global awareness around antimicrobial resistance (AMR) have elevated the demand for reliable AST solutions. Advancements in rapid and automated diagnostic systems are accelerating adoption, particularly in hospitals and diagnostic laboratories. Additionally, integration of AI and machine learning into AST platforms is enhancing precision and efficiency, making AST an essential component of personalized and precision medicine.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.41 Billion
Market Size 2030USD 5.98 Billion
CAGR 2025-20305.17%
Fastest Growing SegmentDrug Development
Largest MarketNorth America

Key Market Drivers

Increase in Prevalence of Infectious Diseases

The rising incidence of infectious diseases, including influenza, tuberculosis, pneumonia, and COVID-19, is significantly driving demand for antimicrobial susceptibility testing. As pathogens evolve and resistance increases, AST has become critical for selecting effective treatments and minimizing inappropriate antibiotic usage. For instance, COVID-19 underscored the need for robust diagnostic infrastructure to manage outbreaks and inform treatment protocols. Similarly, pneumonia remains a leading cause of mortality among children globally, particularly in low-income regions. AST helps clinicians identify suitable antimicrobials, thereby improving patient outcomes and reducing AMR risks. The growing dependence on AST for both routine and emergent infectious disease management continues to fuel market growth.

Key Market Challenges

Lack of Standardization and Validation

A major obstacle in the AST market is the absence of standardized procedures and validation protocols across different testing platforms and laboratories. The variation in testing methods can lead to inconsistent results, complicating clinical interpretation and undermining treatment efficacy. Without uniform guidelines, healthcare providers may struggle to compare susceptibility data across institutions or regions. The validation of new AST technologies is also resource-intensive, involving extensive trials to meet regulatory requirements. In developing regions, limited infrastructure and training further exacerbate the issue. These inconsistencies can delay adoption and hinder efforts to combat antimicrobial resistance effectively. Establishing global standards and robust validation processes is essential to address this challenge.

Key Market Trends

Shift Towards Automated and High-Throughput Systems

The global AST market is increasingly embracing automation and high-throughput platforms to meet rising diagnostic demand. Automated AST systems offer faster turnaround times, higher accuracy, and improved workflow efficiency, making them ideal for high-volume clinical settings. These systems reduce human error and enable large-scale sample processing, essential for timely identification of effective therapies. Integration with laboratory information systems (LIS) allows seamless data management and reporting. High-throughput capabilities are particularly critical as healthcare facilities face increasing caseloads due to infectious diseases and AMR. This trend toward automation is reshaping the diagnostic landscape, providing scalable, reliable solutions for modern healthcare environments.

Key Market Players

  • Bio-Rad Laboratories Inc.
  • Merck & Co., Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • bioMerieux SA
  • Becton, Dickinson and Company
  • ELITech Group SAS
  • F. Hoffmann-La Roche Ltd.
  • Accelerate Diagnostics, Inc.
  • HiMedia Laboratories Private Limited

Report Scope:

In this report, the Global Antimicrobial Susceptibility Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Antimicrobial Susceptibility Testing Market, By Product:

  • Manual Tests
    • MIC Strips
    • Susceptibility Testing Disks
    • Susceptibility Plates
  • Automated Instruments
  • Consumables & Media

Antimicrobial Susceptibility Testing Market, By Technique:

  • Automated AST
  • Etest Method
  • Dilution
  • Disk Diffusion
  • Others

Antimicrobial Susceptibility Testing Market, By Application:

  • Drug Development
  • Susceptibility Testing
  • Others

Antimicrobial Susceptibility Testing Market, By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Others

Antimicrobial Susceptibility Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Antimicrobial Susceptibility Testing Market.

Available Customizations:

Global Antimicrobial Susceptibility Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Antimicrobial Susceptibility Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Manual Tests {MIC Strips, Susceptibility Testing Disks, Susceptibility Plates}, Automated Instruments, Consumables & Media)
    • 5.2.2. By Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, Others)
    • 5.2.3. By Application (Drug Development, Susceptibility Testing, Others)
    • 5.2.4. By End User (Hospitals, Diagnostic Laboratories, Biotechnology & Pharmaceutical Companies, Others)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Antimicrobial Susceptibility Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Antimicrobial Susceptibility Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Antimicrobial Susceptibility Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Antimicrobial Susceptibility Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Antimicrobial Susceptibility Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Antimicrobial Susceptibility Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Antimicrobial Susceptibility Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Antimicrobial Susceptibility Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Antimicrobial Susceptibility Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Antimicrobial Susceptibility Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Bio-Rad Laboratories Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Merck & Co., Inc.
  • 14.3. Thermo Fisher Scientific Inc.
  • 14.4. Danaher Corporation
  • 14.5. bioMerieux SA
  • 14.6. Becton, Dickinson and Company
  • 14.7. ELITech Group SAS
  • 14.8. F. Hoffmann-La Roche Ltd.
  • 14.9. Accelerate Diagnostics, Inc.
  • 14.10. HiMedia Laboratories Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer